Amneal Pharmaceuticals, Inc. Class A Common Stock AMRX
$17.01
+0.83%
at last close
Financials (TTM)
- Revenue
- $3.12 billion
- Net Income
- $215.32 million
- Net Margin
- 6.91%
- Return on Equity
- 652.01%
- Debt-to-Equity
- 77.83
- P/E Ratio
- 34.71
- Price / Book
- 179.40
- Price / Sales
- 1.90
Over the trailing twelve months, Amneal Pharmaceuticals, Inc. Class A Common Stock generated revenue of $3.12 billion and net income of $215.32 million, a net margin of 6.91%.
At the last closing price of $17.01, AMRX trades at 34.71 times trailing earnings and 1.90 times sales, with a market capitalization of $5.92 billion.
Key Stats
- Last Close
- $17.01
- Market Cap
- $5.92 billion
- 52-Week Range
- $8.50 – $19.26
- Average Volume
- 1.72 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.